Meyka Pro banner
HeartBeam, Inc.

HeartBeam, Inc. Fundamental Analysis (NASDAQ: BEATW)

BEATWNASDAQ
HealthcareMedical - Healthcare Information Services
$0.02
$0.001(3.61%)
U.S. Market opens in 2h 57m

HeartBeam, Inc. Fundamental Analysis (NASDAQ: BEATW)

HeartBeam, Inc. (NASDAQ: BEATW) shows weak financial fundamentals with a PE ratio of -1.06, profit margin of 0.00%, and ROE of -10.34%. The company generates N/A in annual revenue with weak year-over-year growth of 0.00%.

Key Strengths

Cash Position13.82%
PEG Ratio-0.04

Areas of Concern

ROE-10.34%
Operating Margin0.00%
Current Ratio0.74
We analyze BEATW's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -1010.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-1010.9/100

We analyze BEATW's fundamental strength across five key dimensions:

Efficiency Score

Weak

BEATW struggles to generate sufficient returns from assets.

ROA > 10%
-5.15%

Valuation Score

Excellent

BEATW trades at attractive valuation levels.

PE < 25
-1.06
PEG Ratio < 2
-0.04

Growth Score

Moderate

BEATW shows steady but slowing expansion.

Revenue Growth > 5%
0.00%
EPS Growth > 10%
15.07%

Financial Health Score

Moderate

BEATW shows balanced financial health with some risks.

Debt/Equity < 1
0.00
Current Ratio > 1
0.74

Profitability Score

Weak

BEATW struggles to sustain strong margins.

ROE > 15%
-1034.04%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is BEATW Expensive or Cheap?

P/E Ratio

BEATW trades at -1.06 times earnings. This suggests potential undervaluation.

-1.06

PEG Ratio

When adjusting for growth, BEATW's PEG of -0.04 indicates potential undervaluation.

-0.04

Price to Book

The market values HeartBeam, Inc. at 38.69 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

38.69

EV/EBITDA

Enterprise value stands at -1.77 times EBITDA. This is generally considered low.

-1.77

How Well Does BEATW Make Money?

Net Profit Margin

For every $100 in sales, HeartBeam, Inc. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-10.34 in profit for every $100 of shareholder equity.

-10.34%

ROA

HeartBeam, Inc. generates $-5.15 in profit for every $100 in assets, demonstrating efficient asset deployment.

-5.15%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.34 in free cash annually.

$-0.34

FCF Yield

BEATW converts -43.75% of its market value into free cash.

-43.75%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.06

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.04

vs 25 benchmark

P/B Ratio

Price to book value ratio

38.69

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.74

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-10.34

vs 25 benchmark

ROA

Return on assets percentage

-5.15

vs 25 benchmark

ROCE

Return on capital employed

-32.05

vs 25 benchmark

How BEATW Stacks Against Its Sector Peers

MetricBEATW ValueSector AveragePerformance
P/E Ratio-1.0631.50 Better (Cheaper)
ROE-1034.04%422.00% Weak
Net Margin0.00%19867.00% Weak
Debt/Equity0.000.53 Strong (Low Leverage)
Current Ratio0.745.56 Weak Liquidity
ROA-514.91%1571.00% Weak

BEATW outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews HeartBeam, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-376.74%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-464.84%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ